Dr. Manasi Shah

Dr. Manasi Shah is a highly respected oncologist with over 10 years of experience in diagnosing and treating patients with cancer. She specialises in treating varied solid tumor pathologies with focus in breast and gynaecological malignancies (ovarian, uterine, and cervical cancers). She is also a part of several national and international trials, working to improve the standard of care for cancer patients in India and to improve access to newer drugs. Dr. Shah is board certified by the American Board of Medicine in Medical Oncology and Haematology and is a part of multiple national and international oncology societies.

• Shah M, Saif MW, Pancreatic Cancer and Thrombosis: Highlights from the “2010 ASCO Annual Meeting”. J Pancreas (Online) 2010 Jul YY; 11(4):331-333    
• Saif MW, Shah M., K-ras mutations in colorectal cancer: a practice changing discovery, Clin Adv Hematol Oncol. 2009 Jan;7(1):45-64.
• Saif MW, Shah M, Shah A, Fluoropyrimidine associated cardiotoxicity: revisited, Expert Opinion in Drug Safety, 2009 March: 8 (2): 191-202.    
• Shah M, Summerhill E, Manthous CA, Medical Professionalism in the New Millennium: Are there intercultural differences?, Conn Med. 2009 May;73(5):289-94.  
• Shah M, Agarwal B, Recent advances in management of acute myeloid leukemia (AML), Indian J Pediatr. 2008 Aug;75(8):831-7.
• Lindner R, Offor O, Chaves J, Fischbach N, Shah M, Activation of the Insulin-LikeGrowth Factor Pathway distinguishes African American from European American patients with triple-negative breast cancer by Gene Expression Profiling, Annual San Antonio Breast cancer Symposium, December 2009    
• Shah M, Fischbach N, Outcomes of triple negative breast cancer in African-Americans vs. Caucasians: a community based study, Annual San Antonio Breast Cancer Symposium, December 2008.